| Literature DB >> 33204985 |
Rosie Freer1, Alexandra Rowett2, C Fielder Camm3.
Abstract
BACKGROUND: Case reports are subject to significant variation in their content, and the absence of pertinent case details can limit their benefit to the medical community. To aid this, a reporting standard (CARE) has been developed. Case reports published in European Heart Journal - Case reports (EHJ-CR) are subject to specific checks by editors to confirm compliance with the CARE reporting standard. However, a degree to which case reports published by EHJ-CR comply with the CARE reporting standards has not been established.Entities:
Keywords: Audit; CARE; Case reports; Reporting standards
Year: 2020 PMID: 33204985 PMCID: PMC7649503 DOI: 10.1093/ehjcr/ytaa251
Source DB: PubMed Journal: Eur Heart J Case Rep ISSN: 2514-2119
Adherence to CARE reporting standard items by case reports published in 2018
| Topics | Item | Checklist item description |
|
|---|---|---|---|
| Title | 1 | Must contain the words ‘case report’, ‘case study’, or ‘case series’ | 129 (99) |
| Key words | 2 | 3–7 key words that identify areas covered in the case report (include ‘case report/study/series’ as one of the key words) | 123 (95) |
| Abstract | 3a | Introduction—what is unique or educational | 90 (69) |
| 3b | Case summary, including; symptoms, clinical findings, diagnosis, interventions, and outcomes | 38 (29) | |
| 3c | Conclusion | 125 (96) | |
| Introduction | 4 | A brief background summary of the case, referencing medical literature | 109 (84) |
| Patient information | 5a | De-identified demographic and patient-specific information | 127 (98) |
| 5b | Presenting complaint including the timing of symptoms if appropriate | 89 (68) | |
| 5c | Relevant past medical and social history | 122 (94) | |
| Clinical findings | 6 | Relevant physical examination findings | 121 (93) |
| Timeline | 7 | Inclusion of data in a table which establishes the sequence of events which comprise the patient’s history and presentation | 130 (100) |
| Diagnostic assessment | 8ai | Diagnostic methods (including lab testing, imaging, surveys) | 129 (99) |
| 8aii | Normal values for any reported diagnostic studies reported in brackets where appropriate | 126 (97) | |
| 8b | Diagnostic challenges (including financial, language, cultural, and technical) | 46 (35) | |
| 8c | Diagnostic reasoning, including other diagnoses considered | 71 (55) | |
| 8d | Prognostic characteristics | 81 (62) | |
| Therapeutic intervention | 9a | Intervention type clearly stated (can include pharmacological, surgical, and preventative) | 129 (99) |
| 9b | Details of how the intervention was administered, including dosage, strength, and duration | 56 (43) | |
| 9c | Any changes in intervention with rationale | 67 (52) | |
| Follow-up and outcomes | 10a | Patient-reported outcomes | 101 (78) |
| 10b | Clinician-assessed outcomes | 114 (88) | |
| 10c | Follow-up intervention and tolerability to the main intervention, with compliance specifically discussed | 20 (15) | |
| 10d | Adverse and unanticipated events as a result of any intervention | 50 (38) | |
| Discussion | 11a | Strengths and limitations of the management of this case | 107 (82) |
| 11b | Discussion of relevant medical literature | 130 (100) | |
| 11c | The rationale for any conclusions made | 130 (100) | |
| 11d | The primary ‘take away’ lessons from the case report, stated explicitly | 130 (100) | |
| Additional details | 12 | Detail the patient’s perspective or experience | 6 (5) |
| 13a | Confirmation of informed patient consent. Where not possible, an explanation of why and alternative arrangements should be detailed. | 129 (99) | |
| 13b | Details of funding sources | 17 (13) | |
| 13c | Presence or absence of conflict of interest confirmed | 130 (100) |